Literature DB >> 7033136

Effects of compromising agents on candidosis in mice with persistent infections initiated in infancy.

M N Guentzel, C Herrera.   

Abstract

Oral-intragastric inoculation of infant CFW mice with Candida albicans, leading either to lethality or to persistent infection of long duration, provides a useful model for study of the host-pathogen interrelationships in candidosis. Mice were most susceptible to the lethal effects of challenge when 4 to 6 days of age, increasingly resistant up to 10 to 11 days, and then resistant to doses of C. albicans lethal for the younger animals. Older mice harboring persistent infections of the gastrointestinal tract, originally initiated when the animals were 6 days old, were used to study the effects of agents which commonly are administered to cancer patients or which are known to predispose to candidosis. The broad-spectrum antibiotic chloramphenicol, cortisone acetate, X-irradiation, or single high doses of cyclophosphamide (Cytoxan) resulted in markedly enhanced levels of C. albicans in the gastrointestinal tract without systemic spread. Repeated smaller doses of Cytoxan, or treatment with methotrexate or a combination of cortisone acetate and Cytoxan, produced gastrointestinal candidosis associated with invasion and systemic spread. The data indicate that the persistently infected animals provide a realistic model for studying treatments that precipitate candidosis in humans.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7033136      PMCID: PMC351019          DOI: 10.1128/iai.35.1.222-228.1982

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  18 in total

1.  Pneumocystis and fungal infection in patients with malignancies.

Authors:  J S Remington; S E Anderson
Journal:  Int J Radiat Oncol Biol Phys       Date:  1976 Jan-Feb       Impact factor: 7.038

2.  Disseminated candidiasis. Changes in incidence, underlying diseases, and pathology.

Authors:  R L Myerowitz; G J Pazin; C M Allen
Journal:  Am J Clin Pathol       Date:  1977-07       Impact factor: 2.493

3.  Candida infection of the gastrointestinal tract.

Authors:  P Eras; M J Goldstein; P Sherlock
Journal:  Medicine (Baltimore)       Date:  1972-09       Impact factor: 1.889

4.  Fungaemia and funguria after oral administration of Candida albicans.

Authors:  W Krause; H Matheis; K Wulf
Journal:  Lancet       Date:  1969-03-22       Impact factor: 79.321

5.  The incidence of pathogenic yeasts among open-heart surgery patients-the value of prophylaxis.

Authors:  E G Evans
Journal:  J Thorac Cardiovasc Surg       Date:  1975-09       Impact factor: 5.209

6.  Candida sepsis: pathogenesis and principles of treatments.

Authors:  H H Stone; L D Kolb; C A Currie; C E Geheber; J Z Cuzzell
Journal:  Ann Surg       Date:  1974-05       Impact factor: 12.969

7.  Systemic and gastrointestinal candidiasis of infant mice after intragastric challenge.

Authors:  L M Pope; G T Cole; M N Guentzel; L J Berry
Journal:  Infect Immun       Date:  1979-08       Impact factor: 3.441

8.  Association of infection due to Candida albicans with intravenous hyperalimentation.

Authors:  J Z Montgomerie; J E Edwards
Journal:  J Infect Dis       Date:  1978-02       Impact factor: 5.226

9.  The emergence of candidosis. The dominant postmortem cerebral mycosis.

Authors:  J C Parker; J J McCloskey; R S Lee
Journal:  Am J Clin Pathol       Date:  1978-07       Impact factor: 2.493

10.  Protection of suckling mice from experimental cholera by maternal immunization: comparison of the efficacy of whole-cell, ribosomal-derived, and enterotoxin immunogens.

Authors:  M N Guentzel; L J Berry
Journal:  Infect Immun       Date:  1974-07       Impact factor: 3.441

View more
  15 in total

1.  Intestinal lesions associated with disseminated candidiasis in an experimental animal model.

Authors:  K A Andrutis; P J Riggle; C A Kumamoto; S Tzipori
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

2.  Experimental gastrointestinal and disseminated candidiasis in immunocompromised animals.

Authors:  T J Walsh; P A Pizzo
Journal:  Eur J Epidemiol       Date:  1992-05       Impact factor: 8.082

3.  Anaerobic growth of Candida albicans does not support biofilm formation under similar conditions used for aerobic biofilm.

Authors:  Swarajit K Biswas; W LaJean Chaffin
Journal:  Curr Microbiol       Date:  2005-06-27       Impact factor: 2.188

4.  Individual evolution of digestive tract colonization of holoxenic mice by Candida albicans.

Authors:  S Walbaum; L Dujardin
Journal:  Infect Immun       Date:  1985-05       Impact factor: 3.441

5.  Evaluation of a murine model of hepatic candidiasis.

Authors:  G T Cole; K T Lynn; K R Seshan
Journal:  J Clin Microbiol       Date:  1990-08       Impact factor: 5.948

6.  Mice with persistent gastrointestinal Candida albicans as a model for antifungal therapy.

Authors:  C Herrera; M N Guentzel
Journal:  Antimicrob Agents Chemother       Date:  1982-01       Impact factor: 5.191

7.  Colonization of congenitally athymic, gnotobiotic mice by Candida albicans.

Authors:  E Balish; M J Balish; C A Salkowski; K W Lee; K F Bartizal
Journal:  Appl Environ Microbiol       Date:  1984-04       Impact factor: 4.792

8.  Gastric colonization with Candida albicans.

Authors:  R A Greenfield; W A Joyce
Journal:  Mycopathologia       Date:  1993-04       Impact factor: 2.574

9.  Factors affecting colonization and dissemination of Candida albicans from the gastrointestinal tract of mice.

Authors:  O Ekenna; R J Sherertz
Journal:  Infect Immun       Date:  1987-07       Impact factor: 3.441

10.  Gastrointestinal colonization and systemic dissemination by Candida albicans and Candida tropicalis in intact and immunocompromised mice.

Authors:  L de Repentigny; M Phaneuf; L G Mathieu
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.